Related Experiment Video
Updated: Jul 13, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Consensus recommendations for improving the cancer clinical trial matching environment
1American Cancer Society Cancer Action Network (ACS CAN), Washington, DC, USA.
Identifying cancer clinical trials for patients is crucial. A 2019 summit addressed barriers to trial matching, proposing policy and infrastructure solutions for better coordination and efficiency.
Area of Science:
- Oncology
- Health Services Research
- Clinical Informatics
Background:
- Patient enrollment in cancer clinical trials hinges on matching patient characteristics with trial criteria.
- A significant barrier to clinical trial participation is the lack of onsite matching trials.
- Current site-agnostic cancer clinical trial matching tools and infrastructure are fragmented and not interoperable.
Purpose of the Study:
- To identify policy and infrastructure solutions for improving third-party, site-agnostic cancer clinical trial matching.
- To examine challenges hindering efficient and effective trial matching.
- To propose consensus recommendations for a more coordinated matching environment.
Main Methods:
- Convened a 2019 summit with stakeholders in the cancer clinical trial field.
- Examined existing barriers and challenges in cancer clinical trial matching.
- Developed policy and infrastructure recommendations based on stakeholder input.
Main Results:
- Identified fragmentation and lack of interoperability as key issues in current matching environments.
- Highlighted the need for improved coordination among public and private matching tools.
- Generated consensus recommendations for policy and infrastructure enhancements.
Conclusions:
- Addressing the identified barriers requires coordinated policy and infrastructure solutions.
- Enhanced collaboration can improve the efficiency and frequency of cancer clinical trial matching.
- Implementing recommendations can facilitate greater patient participation in clinical trials.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
04:49Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research
Published on: May 5, 2021
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...